-transparent.png){kind=logo}
Eight (16%) of 50 children receiving adriamycin and 2 (3%) of 60 receiving daunomycin had severe cardiomyopathy with congestive heart failure. All 110 patients received cumulative doses of over 500 mg/m2. The incidence was significantly higher in those who also had incidental cardiac radiation. The electrocardiogram, with few exceptions, provided the first indication of cardiac abnormality. There were no deaths from heart failure. Two had thromboembolic episodes. Recommendations are discussed.
Related Publications
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
January 1975,
Giornale italiano di chemioterapia,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
September 1978,
Cancer treatment reports,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
September 1976,
Cancer treatment reports,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
January 1974,
Cancer chemotherapy reports,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
October 1974,
Cancer research,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
October 1979,
The Journal of antibiotics,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
January 1977,
Neoplasma,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
January 1974,
Bollettino della Societa italiana di cardiologia,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
January 1982,
Giornale italiano di cardiologia,
A C Gilladoga, and
C Manuel, and
C T Tan, and
N Wollner, and
S S Sternberg, and
M L Murphy
May 1980,
American heart journal,
